日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Determination of the Mass Fractions of the Heavy Metals in the Recycled Cellulose Pulp

再生纤维素浆中重金属质量分数的测定

Klemenčić, Mia; Bolanča Mirković, Ivana; Bolf, Nenad; Markić, Marinko

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity

达沙替尼和曲美替尼促进抗肿瘤代谢活性

Eric L Bolf, Thomas C Beadnell, Madison M Rose, Angelo D'Alessandro, Travis Nemkov, Kirk C Hansen, Rebecca E Schweppe

TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice

TRβ 激动剂可抑制雌性小鼠的肿瘤并增强其对未分化甲状腺癌的药物疗效

Noelle E Gillis, Lauren M Cozzens, Emily R Wilson, Noah M Smith, Jennifer A Tomczak, Eric L Bolf, Frances E Carr

Design, Construction and Control of a Manipulator Driven by Pneumatic Artificial Muscles

气动人工肌肉驱动机械臂的设计、构造与控制

Šitum, Željko; Herceg, Srečko; Bolf, Nenad; Ujević Andrijić, Željka

Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells

乳腺癌和甲状腺癌细胞中甲状腺激素受体β的常见肿瘤抑制信号

Eric L Bolf, Noelle E Gillis, Cole D Davidson, Lauren M Cozzens, Sophie Kogut, Jennifer A Tomczak, Seth Frietze, Frances E Carr

Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms

甲状腺激素受体 β 通过基因组机制抑制甲状腺未分化癌中的 PI3K-Akt-mTOR 信号轴

Cole D Davidson, Eric L Bolf, Noelle E Gillis, Lauren M Cozzens, Jennifer A Tomczak, Frances E Carr

Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer

甲状腺激素受体β在未分化型甲状腺癌中诱导肿瘤抑制程序

Bolf, Eric L; Gillis, Noelle E; Davidson, Cole D; Rodriguez, Princess D; Cozzens, Lauren; Tomczak, Jennifer A; Frietze, Seth; Carr, Frances E

The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer

甲状腺激素受体-RUNX2 轴:乳腺癌中的一种新型肿瘤抑制途径

Eric L Bolf, Noelle E Gillis, Michael S Barnum, Caitlin M Beaudet, Grace Y Yu, Jennifer A Tomczak, Janet L Stein, Jane B Lian, Gary S Stein, Frances E Carr

Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine

卡利拉嗪主要代谢物的临床前药效学和药代动力学特征

Kiss, Béla; Némethy, Zsolt; Fazekas, Károly; Kurkó, Dalma; Gyertyán, István; Sághy, Katalin; Laszlovszky, István; Farkas, Bence; Kirschner, Norbert; Bolf-Terjéki, Etelka; Balázs, Ottilia; Lendvai, Balázs

SAT-573 Characterization of the Gene Expression Program of a Mutant Thyroid Hormone Receptor in Anaplastic Thyroid Cancer

SAT-573 突变型甲状腺激素受体基因表达程序在间变性甲状腺癌中的表征

Tandon, N; Yan, S L; Morgan, B P; Weetman, A P; Bolf, Eric; Gillis, Noelle; Tomczak, Jennifer; Stein, Janet; Stein, Gary; Lian, Jane; Frietze, Seth; Carr, Frances